Joint Venture26 Sept 2024, 06:12 pm
Krsnaa Diagnostics Acquires Strategic Stake in India's First PPP Cancer & Cardiac Care Hospitals
AI Summary
Krsnaa Diagnostics Ltd, one of India's largest providers of integrated diagnostic services, has announced a strategic investment in Apulki Healthcare Private Limited (‘Apulki’), India’s first Public Private Partnership (PPP) dedicated for cancer and cardiac care hospital. This collaboration will enhance access to advanced and super specialized diagnostics for cancer & cardiac patients, making a comprehensive suite of integrated diagnostic services available 24X7 under one roof. The partnership will ensure Krsnaa's sustained leadership in the high-growth oncology and cardiac diagnostic segments, with access to Apulki’s planned network of 10+ hospitals across India.
Key Highlights
- Krsnaa Diagnostics acquires strategic stake in India’s first PPP dedicated for Cancer & Cardiac care Hospitals.
- Partnership will cater to the unmet demand for specialized diagnostics, helping improve outcomes for patients from all socioeconomic backgrounds.
- Krsnaa will become the exclusive diagnostics partner for Apulki’s state-of-the-art cancer and cardiac hospitals for the next 30+ years.
- The initial rollout includes two advanced 125+ bedded hospitals in densely populated regions of Pune and Mumbai.
- Partnership will provide seamless, world-class diagnostic services for patients undergoing cancer and cardiac treatment.